Ropinirole Extended-Release Formulation Considerations

Clinical Guidelines and Recommendations

• The American Academy of Sleep Medicine suggests against the standard use of ropinirole for restless legs syndrome due to concerns about long-term adverse effects, particularly augmentation 1
• If used for RLS, ropinirole should be reserved for patients who prioritize short-term symptom reduction over concerns about long-term adverse effects 1

Side Effects and Monitoring

• Common side effects of ropinirole include gastrointestinal effects, somnolence, dizziness, and orthostatic hypotension 2
• Monitor for compulsive behaviors, which are a potential serious side effect of ropinirole, including unusual urges such as gambling, increased sexual urges, uncontrollable shopping, and compulsive eating 2

Patient-Specific Considerations

• Older patients are at particular risk for orthostasis, drug interactions, and hallucinations when taking ropinirole 2

Dosing Considerations

• In clinical studies for RLS, the mean effective dosage was typically lower than the maximum, suggesting that the 2 mg extended-release dose may be sufficient for many patients 3

Potential Adverse Effects

• Be aware of the augmentation phenomenon, characterized by worsening and earlier onset of symptoms in patients initially controlled on ropinirole 2